ArticleAbdominal radiology (New York)2026
Diagnostic performance of dual-layer spectral detector CT derived from the arterial and portal venous phases in small HCC (≤ 30 mm): comparison with multiphase CT and MRI.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivesTo evaluate the diagnostic performance of virtual monoenergetic images (VMIs) at 40 keV obtained from dual-layer spectral CT (DLCT) for small HCC (sHCC, ≤ 30 mm) using the LI-RADS version 2018 (i.e., LR-5) by intraindividual comparison with conventional CT images (CIs) and MRI. MATERIALS AND
methodsFrom February 2020 to December 2024, patients who were at high risk of HCC with at least one small noncystic observation (≤ 30 mm) and who underwent both DLCT and multiphase MRI within one month were retrospectively enrolled. VMIs at 40 keV derived from DLCT in the arterial and portal venous phases were reconstructed. Two blinded radiologists independently evaluated the LI-RADS imaging features and assigned categories to CIs, VMIs, and MRI. Sensitivities and specificities for sHCC were compared across modalities using generalized estimating equations.
resultsIn total, 136 patients (median age, 56 years [IQR, 48-61 years]; 115 males) with 200 treatment-naïve small observations confirmed by pathology or clinical follow-up were studied. There were 118 HCCs, 23 non-HCC malignancies, and 59 benign observations. When the LR-5 criteria were used, VMIs had significantly higher sensitivity than CIs (reader 1, 76.3% vs. 64.4%, p = 0.002; reader 2, 78.0% vs. 66.9%, p = 0.008) for sHCC and comparable sensitivity to MRI (reader 1, 76.3% vs. 74.6%, p = 0.64; reader 2, 78.0% vs. 77.1%, p = 0.81). The specificities were not significantly different across modalities (p = 0.26-0.74).
conclusionsVMIs derived from the arterial and portal venous phases at 40 keV obtained from DLCT had a sensitivity comparable to MRI but superior to CIs for sHCC diagnosis, without impairing specificity. The comparable sensitivity between VMIs and MRI underscores the potential of DLCT as a viable alternative for HCC diagnosis when MRI is contraindicated or unavailable.
Indexed as
Identifiers
41385073What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.